Skip to content

This is a website for UK healthcare professionals only.

This is a promotional website developed and funded by AstraZeneca.

The prescribing information can be found at the bottom of the page

bars

Maintenance

Intended audience is for UK HCPs

Tagrisso® (Osimertinib) Connect –
New Content Coming Soon

Adverse events should be reported. Reporting forms and information can be found at http://yellowcard.mhra.gov.uk/ or
search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events should also be reported to AstraZeneca by visiting https://contactazmedical.astrazeneca.com or by calling 0800 783 0033.

GB-50518
Date of Preparation: December 2023